Banner
Home
Search
Home Resource Library Research The 9th IACFS/ME Research and Clinical Conference summary by Dr. Rosamund Vallings - March 2009
The 9th IACFS/ME Research and Clinical Conference summary by Dr. Rosamund Vallings - March 2009 PDF Print E-mail
Article Index
The 9th IACFS/ME Research and Clinical Conference summary by Dr. Rosamund Vallings - March 2009
Pharmacologic and Non-pharmacologic Treatment Advances
New Developments in Epidemiology
Neuro-endocrine Advances
Infectious Diseases Research
Latest Research in Immunology
Assessment Issues from Biological to Behavioral
New Developments in Pediatric ME/CFS
Research Developments in Genetics
Advances in Brain Functioning
The Japanese Experience
POSTER PRESENTATIONS
WORKSHOPS
All Pages

Peppermill Resort, Reno, Nevada, USA

12-15th March 2009

I was privileged to attend the IACFS/ME 9th International Research and Clinical conference from 12-15th March, 2009 in Reno, Nevada. Attendees from all around the globe were present and much lively discussion ensued following the papers presenting the latest cutting-edge research.

The main conference opened with an invited lecture from Yasuyoshi Watanabe, (Osaka, Japan). He spoke on the importance of Fatigue Science for Human Health. He told us that fatigue is an important bio-alarm, without which we might lapse into unrecoverable exhaustion, or even die. Fatigue is strongly correlated with motivation. Fatigue decreases efficiency, and scientists are extensively analyzing the causes of fatigue, looking at therapy to aid recovery and preventative strategies. Of fatigue related illness, 30% suffer from Chronic Fatigue Syndrome in Japan, of which 1.3% are children. Other main causes of fatigue are other organic illnesses (28%), mental illness (30%), drug side effects and the effects of surgery. The Japanese have developed a new questionnaire and a fatigue scale. Much research is occurring in Japan with the development of large new centers.

Dr Watanabe then focused on Chronic Fatigue Syndrome (CFS), discussing potential immune, biochemical and endocrine biomarkers. Plethysmography, visible and near infra-red markers for analysis of serum samples, gene expression and APISST (which relates to cytokine signals) are all being researched. HHV6 has been found to be physiologically increased in saliva after hard work, with levels improving after holidays. There are increases in HHV7 also after hard work and slightly less so in CFS. HHV6 is directly shed into the saliva, while HHV7 is amplified in the peripheral T cells. Brain function is studied using PET, functional MRI and MEG. Areas of the brain associated with fatigue, pain and attention have been demonstrated. Other CNS abnormalities include: abnormal acetylcarnitine levels in PET scans, reduced binding potential of 5HTT, mood changes shown to relate to the dopamine system, visual task activity lower in CFS on fMRI, and on MRI morphometry, there was volume reduction in the prefrontal cortices. This latter may relate to cortical plasticity, as it improves with CBT.

Work with animal models was discussed, looking at physical and mental fatigue, infections and complex tasks. In general there was shortage of energy for repair, changes in genes and amino acid changes with fatigue.



 
parkinDESIGN logo